1Holmes CL, Patel BM, Russell JA,et al.Physiology of vasopressin relevant to management of septic shock[J]. Chest, 2001, 120: 989-1002.
2Landry DW, Oliver JA. The pathogenesis of vasodilatory shock[J]. N Engl J Med,2001,345: 588-595.
3Wenzel V, Lindner KH. Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor[J]. Cardiovasc Res,2001, 51: 529-541.
4Wenzel V, Ewy GA, Lindner KH. Vasopressin and endothelin during cardiopulmonary resuscitation[J]. Crit Care Med, 2000, 28 (Suppl. N): 233-235.
5Stiell IG, Hebert PC, Wells GA,et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomized controlled trial[J]. Lancet, 2001,358: 105-109.
6Lindner KH, Dirks B, Strohmenger HU, et al. A randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation [J]. Lancet, 1997, 349:535-537.
7Morley P. Vasopressin or epinephrine: which initial vasopressor for cardiac arrests? (Commentary)[J]. Lancet, 2001,358:85-86.
8Biondi-Zoccai G.G. Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis[J]. Resuscitation,2003,59:221-224.
9Anonymous. Part 6: Section 7: Advanced cardiovascular life support. Section 7: Algorithm approach to ACLS emergencies[J]. Circulation, 2000, 102(Suppl I):136-165.
10Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs[J]. Circulation, 1995, 91:215-221.
